[Tropical causes of epilepsy].
BACKGROUND
Eighty-five percent of all epileptics live in tropical regions. Prenatal risk factors, traumatic brain injuries and different parasitic infestations of the central nervous system (CNS) are the reasons behind the high prevalence of epilepsy. This work reviews the main parasitic infestations causing epilepsy in the tropics.


METHODS
Neurocysticercosis is the main cause of focal epilepsy in early adulthood in endemic areas (30-50%). All the phases of cysticerci (viable, transitional and calcified) are associated with epileptic seizures. Anti-cysticercus treatment helps get rid of cysticerci faster and reduces the risk of recurrence of seizures in patients with viable cysts. Symptomatic epilepsy can be the first manifestation of neuroschistosomiasis in patients without any systemic symptoms. The pseudotumoral form can trigger seizures secondary to the presence of granulomas and oedemas in the cerebral cortex. The eggs of Schistosoma japonicum are smaller, reach the CNS more easily and trigger epileptic seizures more frequently. Toxocariasis and sparganosis are other parasitic infestations that can give rise to symptomatic seizures. The risk factors for suffering chronic epilepsy after cerebral malaria are a positive familial history of epilepsy and a history of episodes of fever and cerebral malaria that began with coma or which progressed with multiple, prolonged epileptic seizures. About 20% of patients with cerebral infarction secondary to Chagas disease present late vascular epilepsy as a complication.


CONCLUSIONS
Very few studies have been conducted to examine the prognosis, risk of recurrence and modification of the natural course of seizures associated with tropical parasitic infestations, except for the case of neurocysticercosis.
Carod-Artal
F J
FJ
Servicio de Neurología, Hospital Virgen de Luz, Cuenca, Espana. fjcarod-artal@hotmail.com
D000818:Animals; D000871:Anthelmintics / Q000627:therapeutic use; D001930:Brain Injuries / Q000150:complications; D014355:Chagas Disease / Q000150:complications / Q000188:drug therapy / Q000473:pathology / Q000503:physiopathology; D003937:Diagnosis, Differential; D004827:Epilepsy / Q000209:etiology* / Q000469:parasitology* / Q000473:pathology / Q000503:physiopathology; D006801:Humans; D016779:Malaria, Cerebral / Q000150:complications / Q000188:drug therapy / Q000473:pathology / Q000503:physiopathology; D020019:Neurocysticercosis / Q000150:complications / Q000188:drug therapy / Q000473:pathology / Q000503:physiopathology; D020818:Neuroschistosomiasis / Q000150:complications / Q000188:drug therapy / Q000473:pathology / Q000503:physiopathology; D011379:Prognosis; D012307:Risk Factors; D013031:Sparganosis / Q000150:complications / Q000188:drug therapy / Q000473:pathology / Q000503:physiopathology; D014120:Toxocariasis / Q000150:complications / Q000188:drug therapy / Q000473:pathology / Q000503:physiopathology; D014329:Tropical Climate / Q000009:adverse effects; D015047:Zoonoses
D000871:Anthelmintics